The FDA could allow foreign-made infant formula to be shipped to the U.S. amid a shortage at the shelves. abc15
As the Biden administration tries to put an end to an infant formula shortage around the U.S., the Food and Drug Administration said it could soon allow foreign-made products to enter the market.
“What we are looking to do is make available that supply from abroad that we can assure people will be safe and make it more readily available,” he told CNN. “There are certain requirements that some manufacturers don't meet that don't have so much to do with nutrition or safety that prohibit us being able to allow to import it. We're going to do what we can to increase supply, work with importers so that supply, so long as it is safe, will make it to the U.S.
The recall was prompted after two infants died and two others were hospitalized after consuming Abbott-made infant formula. Abbott said in a statement last week that it could not find any evidence that the infants were sickened by Abbott-made products.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Major baby formula plant should re-open in about two weeks, FDA commissioner saysHe didn't say when the FDA might let the U.S. import baby formula from other countries, which could help with the massive shortage.
Lire la suite »
Will the FDA change how it vets drugs following the Alzheimer's debacle?The accelerated approval of a controversial drug used to treat Alzheimer’s disease has triggered US lawmakers to push for more oversight from the FDA
Lire la suite »
FDA to investigate delay in baby formula plant inspection, commissioner saysRobert Califf said it's 'likely' Abbott Nutrition will resume operations at its Michigan plant within two weeks. He added that the FDA could make an announcement Monday about importing formula from abroad.
Lire la suite »
FDA to investigate delay in baby formula plant inspection, commissioner saysFood and Drug Administration Commissioner Robert Califf said Monday that the agency will investigate why it took so long to dispatch inspectors to the Abbott Nutrition baby formula plant in Michigan.
Lire la suite »
FDA Limits Use of J&J COVID Vaccine Over Blood Clot RiskThe FDA is limiting who can receive the Johnson & Johnson COVID-19 vaccine because of concerns about the risk of a rare blood clotting condition.
Lire la suite »
NPR Cookie Consent and Choices
Lire la suite »